Abstract

LITERATURE REVIEW: NANO STRUCTURED LIPID CARRIER DRUGS FOR THE TREATMENT OF DIFFERENT DISEASES

*Anjali Sudha and Prof. Dr. Jyoti Sinha

.

Abstract

One cutting-edge method of medication administration is nanostructured lipid carriers, or NLCs. Enhanced bioavailability, controlled release, and targeted administration are just a few of the ways these newer drug delivery systems aim to improve upon older ones. Compared to Solid Lipid Nanoparticles (SLNs), NLCs are more malleable and have a less crystalline structure because they are made of a combination of solid and liquid lipids. The several nanostructured lipid carrier (NLC) drugs used to treat small cell lung cancer are covered in detail in this literature review. Using data collected from a variety of periodicals over the last decade, we have produced statistics on a number of drugs. All research projects and their results pertaining to small cell lung cancer management are included. Medications used to treat this illness are described in depth for the benefit of readers. Since lipid carrier drugs have many positive effects at different doses, we will be concentrating on NLC meds here. Terms like "anticancer drugs," "antiinflammatory drugs," and "NLC" come up frequently.

Keywords: SLN, NLC, Extend release, anticancer, anti-inflammatory.